Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

NASDAQ:JBLU - Nasdaq - US4771431016 - Common Stock - Currency: USD

4.41  -0.16 (-3.5%)

After market: 4.4201 +0.01 (+0.23%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JBLU. JBLU was compared to 22 industry peers in the Passenger Airlines industry. Both the profitability and financial health of JBLU have multiple concerns. JBLU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JBLU had negative earnings in the past year.
JBLU had a positive operating cash flow in the past year.
In the past 5 years JBLU always reported negative net income.
Of the past 5 years JBLU 4 years had a positive operating cash flow.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

With a Return On Assets value of -1.68%, JBLU perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
JBLU has a Return On Equity (-11.74%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.68%
ROE -11.74%
ROIC N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

With an excellent Gross Margin value of 67.80%, JBLU belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
JBLU's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for JBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
JBLU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, JBLU has more shares outstanding
Compared to 1 year ago, JBLU has a worse debt to assets ratio.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.68, we must say that JBLU is in the distress zone and has some risk of bankruptcy.
JBLU has a Altman-Z score of 0.68. This is comparable to the rest of the industry: JBLU outperforms 45.45% of its industry peers.
JBLU has a Debt/Equity ratio of 3.31. This is a high value indicating a heavy dependency on external financing.
JBLU has a Debt to Equity ratio (3.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 3.31
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACC5.28%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.01 indicates that JBLU should not have too much problems paying its short term obligations.
JBLU's Current ratio of 1.01 is amongst the best of the industry. JBLU outperforms 90.91% of its industry peers.
JBLU has a Quick Ratio of 1.01. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, JBLU belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.97
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.14%.
Looking at the last year, JBLU shows a decrease in Revenue. The Revenue has decreased by -3.02% in the last year.
Measured over the past years, JBLU shows a small growth in Revenue. The Revenue has been growing by 2.77% on average per year.
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.21%
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-3.12%

3.2 Future

JBLU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.47% yearly.
JBLU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.85% yearly.
EPS Next Y-147.53%
EPS Next 2Y-23.02%
EPS Next 3Y14.47%
EPS Next 5YN/A
Revenue Next Year-2.84%
Revenue Next 2Y2.36%
Revenue Next 3Y3.85%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

1

4. Valuation

4.1 Price/Earnings Ratio

JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JBLU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

JBLU's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.6
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as JBLU's earnings are expected to grow with 14.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.02%
EPS Next 3Y14.47%

0

5. Dividend

5.1 Amount

No dividends for JBLU!.
Industry RankSector Rank
Dividend Yield N/A

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (7/18/2025, 8:00:02 PM)

After market: 4.4201 +0.01 (+0.23%)

4.41

-0.16 (-3.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners89.38%
Inst Owner Change0%
Ins Owners10.36%
Ins Owner Change14.57%
Market Cap1.56B
Analysts47.27
Price Target4.47 (1.36%)
Short Float %17.63%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.78%
Min EPS beat(2)5.75%
Max EPS beat(2)33.81%
EPS beat(4)4
Avg EPS beat(4)61.77%
Min EPS beat(4)5.75%
Max EPS beat(4)169.56%
EPS beat(8)6
Avg EPS beat(8)30.82%
EPS beat(12)8
Avg EPS beat(12)-5.16%
EPS beat(16)12
Avg EPS beat(16)0.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-0.96%
Revenue beat(4)0
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.74%
Revenue beat(8)0
Avg Revenue beat(8)-1.49%
Revenue beat(12)0
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.3%
PT rev (1m)-1.72%
PT rev (3m)-28.71%
EPS NQ rev (1m)8.64%
EPS NQ rev (3m)-828.79%
EPS NY rev (1m)-6.72%
EPS NY rev (3m)-79.37%
Revenue NQ rev (1m)0.82%
Revenue NQ rev (3m)-8.28%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-5.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF 28.94
P/B 0.64
P/tB 0.76
EV/EBITDA 9.6
EPS(TTM)-0.88
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-3.63
FCFYN/A
OCF(TTM)0.15
OCFY3.46%
SpS25.99
BVpS6.9
TBVpS5.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.68%
ROE -11.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.8%
FCFM N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 3.31
Debt/FCF N/A
Debt/EBITDA 14.58
Cap/Depr 201.5%
Cap/Sales 14.55%
Interest Coverage N/A
Cash Conversion 9.73%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.97
Altman-Z 0.68
F-Score5
WACC5.28%
ROIC/WACCN/A
Cap/Depr(3y)199.72%
Cap/Depr(5y)186.25%
Cap/Sales(3y)13.36%
Cap/Sales(5y)16.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.21%
EPS Next Y-147.53%
EPS Next 2Y-23.02%
EPS Next 3Y14.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-3.12%
Revenue Next Year-2.84%
Revenue Next 2Y2.36%
Revenue Next 3Y3.85%
Revenue Next 5YN/A
EBIT growth 1Y-86.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.31%
EBIT Next 3Y92.45%
EBIT Next 5YN/A
FCF growth 1Y-203.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.94%
OCF growth 3Y-55.57%
OCF growth 5Y-36.98%